NDC 0074-3333

Norvir

Ritonavir

Norvir is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Ritonavir.

Product ID0074-3333_2b7d7b43-b76c-3624-d154-0874a0ff7c21
NDC0074-3333
Product TypeHuman Prescription Drug
Proprietary NameNorvir
Generic NameRitonavir
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2010-05-06
Marketing CategoryNDA / NDA
Application NumberNDA022417
Labeler NameAbbVie Inc.
Substance NameRITONAVIR
Active Ingredient Strength100 mg/1
Pharm ClassesHIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],UDP Glucuronosyltransferases Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0074-3333-30

30 TABLET, FILM COATED in 1 BOTTLE (0074-3333-30)
Marketing Start Date2010-05-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0074-3333-30 [00074333330]

Norvir TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA022417
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-05-06

Drug Details

Active Ingredients

IngredientStrength
RITONAVIR100 mg/1

OpenFDA Data

SPL SET ID:2849298e-de6e-47bb-8194-56e075b33fc3
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 152971
  • 900575
  • 900577
  • 1926069
  • 199249
  • 1926066
  • UPC Code
  • 0300743333305
  • Pharmacological Class

    • HIV Protease Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitor [EPC]
    • Protease Inhibitor [EPC]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 2D6 Inhibitors [MoA]
    • Cytochrome P450 2C19 Inducers [MoA]
    • Cytochrome P450 3A Inducers [MoA]
    • P-Glycoprotein Inhibitors [MoA]
    • Breast Cancer Resistance Protein Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 1A2 Inducers [MoA]
    • Cytochrome P450 2C9 Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]
    • UDP Glucuronosyltransferases Inducers [MoA]

    NDC Crossover Matching brand name "Norvir" or generic name "Ritonavir"

    NDCBrand NameGeneric Name
    0074-1940NorvirRitonavir
    0074-2340NorvirRitonavir
    0074-3333NorvirRitonavir
    0074-3399NorvirRitonavir
    50090-1162NorvirRitonavir
    53808-1119NorvirRitonavir
    67296-1234NorvirNorvir
    0054-0407RitonavirRitonavir
    31722-597RitonavirRitonavir
    60687-364RitonavirRitonavir
    60687-420RitonavirRitonavir
    65162-061RitonavirRitonavir
    65862-687RitonavirRitonavir

    Trademark Results [Norvir]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    NORVIR
    NORVIR
    74655713 2001944 Live/Registered
    ABBVIE INC.
    1995-04-04

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.